Epivir HBV and Insulin Glargine (U-100) Cartridge Systems and Pens
Determining the interaction of Epivir HBV and Insulin Glargine (U-100) Cartridge Systems and Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lamivudine
Brand name: Epivir, Epivir HBV
Synonyms: Epivir-HBV
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Epivir HBV-Insulin Glargine (U-100) Vials
- Epivir HBV-Insulin Glargine (U-300) Pens
- Epivir HBV-Insulin glargine and lixisenatide
- Epivir HBV-Insulin glargine and lixisenatide Subcutaneous
- Epivir HBV-Insulin glargine, recombinant Subcutaneous
- Epivir HBV-Insulin glulisine
- Insulin Glargine (U-100) Cartridge Systems and Pens-Epivir-HBV (Lamivudine Oral Solution)
- Insulin Glargine (U-100) Cartridge Systems and Pens-Epivir-HBV (Lamivudine Tablets)
- Insulin Glargine (U-100) Cartridge Systems and Pens-Eplerenone
- Insulin Glargine (U-100) Cartridge Systems and Pens-Epoetin alfa
- Insulin Glargine (U-100) Cartridge Systems and Pens-Epoetin alfa Injection
- Insulin Glargine (U-100) Cartridge Systems and Pens-Epoetin Alfa Vials